毒理病理论坛意见稿:在非临床毒性研究中使用虚拟对照组:解剖病理学的角度
Armelle Grevot1, Julie Boisclair1, Magali Guffroy2
1Novartis Pharma AG, Basel, Switzerland.
Toxicologic pathology
|January 31, 2024
概括
虚拟控制小组 (VCGs) 是减少药物开发中毒性研究中动物使用的有希望的方法. 通过并行研究和数字组织病理学验证VCG对于其采用至关重要.
科学领域:
- 药物开发 药物开发
- 毒理学 毒理学 毒理学
- 兽医病理学 兽医病理学
背景情况:
- 全球越来越多的倡议旨在减少制药研究中的动物试验.
- 虚拟控制组 (VCG) 正在成为非临床毒性研究的新方法.
研究的目的:
- 讨论与在非临床毒性研究中用VCG取代并发对照 (CCs) 相关的挑战和机会.
- 强调在VCG实施中对解剖病理学的具体考虑.
主要方法:
- 讨论毒理学家,病理学家和监管机构之间协调努力的必要性.
- 强调需要一个经过验证的数据库,包括用于VCG评估的数字遗传病理幻灯片.
- 为验证提出双重研究设计 (VCG和CC并行) 和混合方法 (并发和VC).
主要成果:
- 该论文确定了实施VCG的关键挑战,特别是在解剖病理学中.
- 建议通过并行研究和混合方法进行验证,以建立信心.
- 一个包含数字幻灯片的全面数据库被认为是显微镜评估的必要条件.
结论:
- 逐步实施VCGs需要科学家和监管机构之间的合作.
- 经过验证的VCG有潜力显著减少非临床研究中使用的动物数量.
- 建立对VCG的信任将为其更广泛的接受和使用铺平道路.
更多相关视频
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
4.8K
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.4K
相关概念视频
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
